{"schema":"hottub-news/story/v1","story":"st_oud32giy6r2doesz5rsa","title":"8-K - Nano Nuclear Energy Inc. (0001923891) (Filer)","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/8-k-keros-therapeutics-inc-0001664710-filer-oud32giy6r","count":17,"items":[{"id":"n_zpvjvx4zzszjidoxv4fa","seq":1423947,"kind":"official","title":"8-K - Nano Nuclear Energy Inc. (0001923891) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1923891/000149315226045534/0001493152-26-045534-index.htm","summary":"Filed: 2026-10-02 AccNo: 0001493152-26-045534 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits","published":"2026-10-02T20:30:35Z","seen":"2026-10-02T20:49:43Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.3499999940395355,"category2":"science-technology","sentiment":"neutral","tone":-0.11999999731779099,"political":0.17000000178813934},{"id":"n_7pizcudw6yebqugpauja","seq":1109977,"kind":"official","title":"8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226045193/0001493152-26-045193-index.htm","summary":"Filed: 2026-10-01 AccNo: 0001493152-26-045193 Size: 216 KB Item 4.01: Changes in Registrant's Certifying Accountant Item 9.01: Financial Statements and Exhibits","published":"2026-10-01T01:54:04Z","seen":"2026-10-01T10:16:58Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.25,"category2":"economy-business","sentiment":"neutral","tone":-0.10000000149011612,"political":0.029999999329447746},{"id":"n_u4lrs6i4khflx74zelpa","seq":1006323,"kind":"official","title":"8-K - NN INC (0000918541) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/918541/000091854126000100/0000918541-26-000100-index.htm","summary":"Filed: 2026-09-30 AccNo: 0000918541-26-000100 Size: 260 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits","published":"2026-09-30T21:17:24Z","seen":"2026-09-30T21:44:30Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.3799999952316284,"category2":"economy-business","sentiment":"neutral","tone":-0.11999999731779099,"political":0.03999999910593033},{"id":"n_uqhkqlrvjr3ovohjojxq","seq":775745,"kind":"official","title":"8-K - TECHPRECISION CORP (0001328792) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1328792/000110465926111987/0001104659-26-111987-index.htm","summary":"Filed: 2026-09-29 AccNo: 0001104659-26-111987 Size: 344 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits","published":"2026-09-29T21:20:33Z","seen":"2026-09-29T22:25:16Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"science-technology","category_p":0.3400000035762787,"category2":"economy-business","sentiment":"neutral","tone":-0.0,"political":0.05000000074505806},{"id":"n_v4a3brlgdd6hpoz3nm3a","seq":775762,"kind":"official","title":"8-K - Bone Biologics Corp (0001419554) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226044889/0001493152-26-044889-index.htm","summary":"Filed: 2026-09-29 AccNo: 0001493152-26-044889 Size: 278 KB Item 5.07: Submission of Matters to a Vote of Security Holders","published":"2026-09-29T21:00:43Z","seen":"2026-09-29T22:25:16Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.25999999046325684,"sentiment":"neutral","tone":0.09000000357627869,"political":0.009999999776482582},{"id":"n_3t6qsysthwag36bpkwtq","seq":766398,"kind":"official","title":"8-K - NANOVIRICIDES, INC. (0001379006) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926111952/0001104659-26-111952-index.htm","summary":"Filed: 2026-09-29 AccNo: 0001104659-26-111952 Size: 221 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits","published":"2026-09-29T20:30:20Z","seen":"2026-09-29T20:53:28Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.46000000834465027,"sentiment":"neutral","tone":-0.25999999046325684,"political":0.07000000029802322},{"id":"n_n6mrzhrkgngoabjjmuxq","seq":760550,"kind":"official","title":"8-K - Modular Medical, Inc. (0001074871) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390026104656/0001213900-26-104656-index.htm","summary":"Filed: 2026-09-29 AccNo: 0001213900-26-104656 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","published":"2026-09-29T20:10:20Z","seen":"2026-09-29T20:20:20Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.28999999165534973,"category2":"health","sentiment":"neutral","tone":-0.10999999940395355,"political":0.07000000029802322},{"id":"n_cdjf4dldodn67wso3ska","seq":668197,"kind":"official","title":"8-K - Keros Therapeutics, Inc. (0001664710) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000059/0001664710-26-000059-index.htm","summary":"Filed: 2026-09-29 AccNo: 0001664710-26-000059 Size: 167 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits","published":"2026-09-29T12:01:22Z","seen":"2026-09-29T12:31:52Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.2800000011920929,"category2":"crime-law","sentiment":"neutral","tone":-0.05999999865889549,"political":0.029999999329447746},{"id":"n_eb5qlvrl7xajfwerwd4a","seq":661732,"kind":"official","title":"8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026104314/0001213900-26-104314-index.htm","summary":"Filed: 2026-09-29 AccNo: 0001213900-26-104314 Size: 231 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits","published":"2026-09-29T11:46:32Z","seen":"2026-09-29T12:00:27Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"entities":[{"id":"Q139379676","name":"Unicycive Therapeutics, Inc.","type":"org"}],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.28999999165534973,"sentiment":"neutral","tone":-0.07000000029802322,"political":0.05000000074505806},{"id":"n_zyw7xeien3zb4hr33dfq","seq":517766,"kind":"official","title":"8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026104076/0001213900-26-104076-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001213900-26-104076 Size: 198 KB Item 8.01: Other Events","published":"2026-09-28T20:31:05Z","seen":"2026-09-28T20:33:39Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"entities":[{"id":"Q139379676","name":"Unicycive Therapeutics, Inc.","type":"org"}],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.28999999165534973,"sentiment":"neutral","tone":-0.07000000029802322,"political":0.05000000074505806},{"id":"n_bmllphvv36duovxwcaeq","seq":517772,"kind":"official","title":"8-K - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/867840/000168316826007465/0001683168-26-007465-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001683168-26-007465 Size: 344 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits","published":"2026-09-28T20:30:14Z","seen":"2026-09-28T20:33:39Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.33000001311302185,"category2":"crime-law","sentiment":"neutral","tone":-0.03999999910593033,"political":0.029999999329447746},{"id":"n_zihg62wvryqzdspsiida","seq":517773,"kind":"official","title":"8-K - TELEDYNE TECHNOLOGIES INC (0001094285) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1094285/000109428526000050/0001094285-26-000050-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001094285-26-000050 Size: 197 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits","published":"2026-09-28T20:27:53Z","seen":"2026-09-28T20:33:39Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"crime-law","category_p":0.28999999165534973,"category2":"economy-business","sentiment":"neutral","tone":-0.09000000357627869,"political":0.03999999910593033},{"id":"n_c736zrdjbrw43hivld5q","seq":455986,"kind":"official","title":"8-K/A - CORE MOLDING TECHNOLOGIES INC (0001026655) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1026655/000102665526000067/0001026655-26-000067-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001026655-26-000067 Size: 172 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits","published":"2026-09-28T14:09:53Z","seen":"2026-09-28T14:55:21Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.44999998807907104,"category2":"science-technology","sentiment":"neutral","tone":-0.029999999329447746,"political":0.019999999552965164},{"id":"n_v2rco4d3n4zcoqb2wlia","seq":455987,"kind":"official","title":"8-K - CORE MOLDING TECHNOLOGIES INC (0001026655) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1026655/000102665526000062/0001026655-26-000062-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001026655-26-000062 Size: 15 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits","published":"2026-09-28T13:37:45Z","seen":"2026-09-28T14:55:21Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.4300000071525574,"category2":"science-technology","sentiment":"neutral","tone":-0.05999999865889549,"political":0.029999999329447746},{"id":"n_tm5b5wnbyvd3ipvhdrza","seq":455999,"kind":"official","title":"8-K - CORE MOLDING TECHNOLOGIES INC (0001026655) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1026655/000102665526000059/0001026655-26-000059-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001026655-26-000059 Size: 167 KB Item 5.01: Changes in Control of Registrant Item 9.01: Financial Statements and Exhibits","published":"2026-09-28T12:52:42Z","seen":"2026-09-28T14:55:21Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.4300000071525574,"category2":"science-technology","sentiment":"neutral","tone":-0.05999999865889549,"political":0.029999999329447746},{"id":"n_zkid52l47kayvendgpja","seq":422123,"kind":"official","title":"8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1650648/000119312526403424/0001193125-26-403424-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001193125-26-403424 Size: 150 KB Item 8.01: Other Events","published":"2026-09-28T12:05:05Z","seen":"2026-09-28T12:20:49Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"entities":[{"id":"Q124433826","name":"4D Molecular Therapeutics, Inc.","type":"org"}],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.3100000023841858,"category2":"health","sentiment":"neutral","tone":-0.05000000074505806,"political":0.029999999329447746},{"id":"n_oud32giy6r2doesz5rsa","seq":422127,"kind":"official","title":"8-K - Keros Therapeutics, Inc. (0001664710) (Filer)","url":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000056/0001664710-26-000056-index.htm","summary":"Filed: 2026-09-28 AccNo: 0001664710-26-000056 Size: 169 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits","published":"2026-09-28T12:01:07Z","seen":"2026-09-28T12:20:49Z","lang":"en","country":"US","source":{"id":"sec-edgar","name":"SEC EDGAR (current filings","domain":"sec.gov","outlet":{"wikidata":"Q953944","name":"United States Securities and Exchange Commission","type":"government","country":"US","designations":["financial regulatory agency","independent agency of the united states government","regulatory agency"]}},"via":"sec-edgar","topics":["form type"],"story":"st_oud32giy6r2doesz5rsa","category":"economy-business","category_p":0.2800000011920929,"category2":"crime-law","sentiment":"neutral","tone":-0.05999999865889549,"political":0.029999999329447746}]}